Company intelligence / Profile preview

SCD Probiotics

Kansas City, Missouri, United States
Ownership
Private
Employees
~51
Development stage
Other
01

Overview

SCD Probiotics is a Kansas City-based life sciences and industrial biotechnology company focused on probiotic- and postbiotic-based products for human health, agriculture, companion animal health, home care, and environmental applications. Founded in 1998 by Matt Wood, the company develops and manufactures live microbial consortia and fermented biochemical products rather than repackaging isolated probiotic strains. Its technology platform centers on patented Mother Cultures and microbial consortia that are licensed to partners and used to create finished products across multiple end markets. SCD Probiotics operates commercially and appears to function as a wholly owned subsidiary of Probiotic Holdings, which holds related manufacturing, R&D, and quality certifications. The business is better characterized as a commercial microbiome and bio-based products company than as a therapeutics developer with a traditional drug pipeline.

Therapeutic areas
ImmunologyOtherGastroenterology
Modalities
Live biotherapeutic product therapyMicrobial therapyBiologic
Industry
Non-Drug Biotech
02

Partnerships

Blue AquaRallis IndiaGlobal Saude BrasilStahl HoldingsCromogenia UnitsProklean TechnologiesProbiotics PolskaThai Nam Viet Bioscience Technology

Beyond the preview

Go deeper on SCD Probiotics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SCD Probiotics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call